# GPT 5.2 Review - Round 6/10

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-18T04:17:07.010661
**Response ID:** resp_064dfe2dd639f87800696c4fe9ef288195be098962de26cf50
**Tokens:** 16965 in / 6726 out
**Response SHA256:** 6e9b23be0c0ee9f0

---

## PHASE 1: FORMAT REVIEW

1. **Length (≥25 pages excl. refs/appendix)**: **PASS**  
   - Main text appears to run roughly pp. 1–28 (refs start around p. 29; appendix figures afterward), so ≥25 pages excluding references/appendix.

2. **References (≥15 citations)**: **PASS**  
   - Bibliography lists well over 15 entries (≈25+).

3. **Prose Quality (no bullet-point sections)**: **PASS**  
   - Introduction, Background/Literature, Results, and Discussion are written in paragraphs (no bullet-format sections).

4. **Section Completeness (3–4 substantive paragraphs each)**: **PASS**  
   - Introduction, Background, Data/Strategy, Results, and Conclusion all have multiple substantive paragraphs.

5. **Figures (visible data, not broken)**: **PASS**  
   - Figures shown (SCM plot, DiD coefficient plot, event study plot) display visible data with labeled axes and CIs/lines.

6. **Tables (real numbers, no placeholders)**: **PASS**  
   - Tables contain numeric estimates, SEs, and sample sizes; no “TBD/XXX”.

### PHASE 1 VERDICT
**PHASE 1: PASS - Proceeding to content review**

---

## PHASE 2: CONTENT REVIEW (Top-journal standards)

### 1) STATISTICAL METHODOLOGY (NON-NEGOTIABLE)

**a) Standard errors reported:** **PASS**  
- Table 2 and Table 3 report SEs in parentheses.

**b) Significance testing:** **PASS**  
- Significance stars and some p-values are provided.

**c) Confidence intervals for main results:** **WARN**  
- For regressions, CIs are computable from SEs; figures show 95% CIs. But tables do not directly report CIs and some narrative claims rely on informal interpretation.

**d) Sample sizes reported:** **PASS**  
- N is reported in Tables 1–3; control means are provided.

**e) DiD with staggered adoption:** **FAIL (publishability-critical)**  
- The main estimating equation (state FE + cohort FE + survey-year FE, with a “Fully treated” indicator) is essentially a **TWFE-style DiD** applied to **staggered adoption**.  
- The paper *discusses* Goodman-Bacon/Sun-Abraham/Callaway–Sant’Anna, but **does not implement an estimator designed for staggered timing** (e.g., Callaway & Sant’Anna group-time ATT, Sun & Abraham interaction-weighted event study, Borusyak-Jaravel-Spiess imputation, or stacked DiD).  
- Even if your substantive conclusion is “identification fails,” top-field standards still require showing that the finding is not an artifact of a known-bad estimator. Right now, a reader can object: “your negative/odd estimates and pre-trends are partly a TWFE artifact.”

**Additional inference concern (not explicitly in the checklist, but severe):**
- You cluster by birth state with **only 16 clusters** (Table 2 notes this). You acknowledge few-cluster issues (Section 5.4) and mention wild cluster bootstrap, but the bootstrap results are not shown in the excerpted tables. In a top journal, **few-cluster-robust inference must be front-and-center**, with reported bootstrap/randomization-inference p-values for the headline coefficients.

**Bottom line on methodology:** Because item (e) fails, the paper is **not publishable in its current form**, regardless of how careful the narrative is about limitations.

---

### 2) Identification Strategy

You are admirably explicit that the design is not credible because early-ban (mostly NE) vs never-ban (mostly South) states likely violate parallel trends. However, the paper currently lands in an uncomfortable middle: it runs a standard TWFE-style design, finds “weird” results, and concludes “therefore confounding.”

Key issues:

1. **Internal coherence of the specification (possible collinearity):**  
   - You say you include **birth cohort FE + survey year FE + age (linear)** (Section 3.2–3.3; Table 2 notes “Controls include … age”). But age is mechanically `survey_year - birth_year`. With full cohort FE and survey-year FE, **age is collinear** (or nearly so if cohorts are binned). You need to clarify whether cohort FE are coarse bins, whether age is actually excluded in estimation, or whether survey-year FE are excluded. As written, it suggests an impossible specification.

2. **Treatment assignment validity (state of birth ≠ state of schooling):**  
   - You treat state-of-birth policy as exposure. That’s common with ACS, but for long-run K–12 exposure it’s a major threat. You discuss attenuation (Section 5.2), but you do not bound it or validate it. At minimum, do sensitivity: restrict to **low-mobility individuals** (e.g., those currently residing in birth state) as a proxy; show robustness.

3. **“Fully treated vs never treated” restriction:**  
   - Excluding partially treated cohorts can reduce “dosage” ambiguity, but it also changes identifying variation and can induce selection on cohorts/states. You should show results including partial treatment with a continuous exposure measure (years under ban during ages 6–18), or use an interaction-weighted/event-study framework with proper estimators.

4. **Event-study evidence is not yet decisive by top-journal standards:**  
   - You claim “clear violations of parallel trends.” The plotted pre-coefficients in Figure 3 appear mixed and (depending on CI width) may not individually differ from zero; what matters is a **joint test** of all leads and a transparent description of reference groups and weights.  
   - Also, your event-study is restricted to “states that eventually banned.” That can be appropriate for timing designs, but then you must be explicit about the estimator (Sun-Abraham vs TWFE) because TWFE event studies are exactly where “forbidden comparisons” bite.

5. **Synthetic control analysis is underpowered and not standardly validated:**  
   - You run SCM for Massachusetts with a donor pool of six Southern never-ban states and declare failure due to RMSPE 0.635. Two concerns:
     - SCM usually uses **a larger donor pool** unless there is a principled restriction (and then you must justify why that restriction is necessary and what tradeoff it imposes).  
     - SCM inference typically uses **placebo/permutation tests** (in-space and/or in-time) and reports post/pre RMSPE ratios. Those are not shown.  
   - Poor fit may be real, but you need to demonstrate it is robust to predictor sets, donor pools, and the use of **augmented SCM / SDID** (Arkhangelsky et al. 2021) across multiple treated states, not just a single canonical early adopter.

Overall: I agree with the *direction* of your conclusion (“this state-level NE-vs-South contrast is not a credible counterfactual”), but the paper does not yet meet the evidentiary burden to publish that conclusion in a top economics journal.

---

### 3) Literature (missing references + BibTeX)

You cite much of the recent staggered-adoption DiD literature (Goodman-Bacon; Sun-Abraham; Callaway–Sant’Anna; Roth; Rambachan–Roth; Borusyak et al.), and classic SCM/SDID references. However, you are missing **canonical DiD foundations** that a top journal referee will expect, especially given your paper’s methodological angle.

**Missing / strongly recommended citations:**

1) **Abadie (2005)** — semiparametric DiD; foundational for DiD beyond TWFE.  
```bibtex
@article{Abadie2005,
  author = {Abadie, Alberto},
  title = {Semiparametric Difference-in-Differences Estimators},
  journal = {Review of Economic Studies},
  year = {2005},
  volume = {72},
  number = {1},
  pages = {1--19}
}
```

2) **Imbens and Wooldridge (2009)** — canonical program evaluation overview including DiD assumptions and practice.  
```bibtex
@article{ImbensWooldridge2009,
  author = {Imbens, Guido W. and Wooldridge, Jeffrey M.},
  title = {Recent Developments in the Econometrics of Program Evaluation},
  journal = {Journal of Economic Literature},
  year = {2009},
  volume = {47},
  number = {1},
  pages = {5--86}
}
```

3) **Card and Krueger (1994)** — canonical applied DiD exemplar; useful for framing and benchmarking identification discussion.  
```bibtex
@article{CardKrueger1994,
  author = {Card, David and Krueger, Alan B.},
  title = {Minimum Wages and Employment: A Case Study of the Fast-Food Industry in New Jersey and Pennsylvania},
  journal = {American Economic Review},
  year = {1994},
  volume = {84},
  number = {4},
  pages = {772--793}
}
```

If you want to position the paper as “a cautionary tale,” it may also help to cite a modern “DiD practice” reference (e.g., a DiD review/synthesis), but only include it if you can cite it accurately (journal/working paper).

---

### 4) Writing Quality

Strengths:
- The narrative is clear and unusually transparent about identification problems (Sections 4.4–5.1; Conclusion).
- The mechanisms section is well-organized and makes clear what signs would be implausible (e.g., disability increasing).

Weaknesses:
- Some claims read stronger than the evidence presented. E.g., “clear violations” should be backed by joint pre-trend tests and/or honest DiD sensitivity intervals, not only visual inspection.
- There are places where specification details are underspecified (exact cohort FE definition; whether age is included despite collinearity).

---

### 5) Figures and Tables

- Tables 2–3 are readable and include core ingredients (SEs, FE indicators, N).  
- Figure labels are mostly clear.
- But for publication-quality econometrics, you need:
  - A figure/table showing **dynamic effects using a valid staggered-adoption estimator** (Sun-Abraham or C&S).
  - A figure/table reporting **few-cluster-robust inference** (wild cluster bootstrap p-values, randomization inference, and/or Conley–Taber style).

---

## Overall Assessment

### Key strengths
- Important policy question with large administrative-scale microdata (ACS).
- High transparency: you do not oversell causal claims and emphasize diagnostics.
- The paper could be valuable as a “what not to do / why this setting is hard” piece—*if* executed with best-practice estimators and formal diagnostics.

### Critical weaknesses (blocking)
1. **Primary DiD estimator is TWFE-style in a staggered-adoption setting** without implementing modern alternatives. This is a first-order publishability problem.
2. **Few-cluster inference is not adequately reported** for headline results.
3. **Potential model collinearity** (age + cohort FE + survey-year FE) needs resolution/clarification.
4. SCM section is not yet persuasive without placebo inference and robustness to donor/predictor choices.

### Specific improvements required for a serious resubmission
- Re-estimate effects using at least one of:
  - **Callaway & Sant’Anna (2021)** group-time ATT with never-treated controls,
  - **Sun & Abraham (2021)** interaction-weighted event study,
  - **Borusyak, Jaravel & Spiess (2024)** imputation estimator,
  - **Stacked DiD** designs that avoid already-treated controls.
- Report **joint pre-trends tests**, and consider **Rambachan–Roth** sensitivity/bounds (“how large a deviation from parallel trends would overturn conclusions?”).
- Address **few clusters** with reported **wild cluster bootstrap** p-values (and/or randomization inference).
- Fix/clarify **age/cohort/year** collinearity.
- Strengthen the “SCM fails” claim via:
  - SDID across multiple treated states, not only MA,
  - placebo tests (in-space), post/pre RMSPE ratios, and alternative donor pools.
- Consider a **within-region design**: restrict to states within the South (or within Census divisions) where adoption differs, or do a **border-county / border-PUMA** approach to reduce regional confounding.

---

## VERDICT (REQUIRED)

**VERDICT: REJECT**

Rationale: Under top-journal standards, the paper’s core empirical analysis relies on a TWFE-style approach in a staggered-adoption DiD context without implementing valid modern estimators, and inference with 16 clusters is not adequately reported. Even though the paper argues “identification fails,” that conclusion itself must be demonstrated using state-of-the-art estimators and formal sensitivity/inference procedures.